Kawahira, Masahiro <br/><br/>
Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.  [electronic resource] 

 -  International journal of clinical oncology  Dec 2018 
 - 1189-1195 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1437-7772 
<br/><br/><label>Standard No.: </label>10.1007/s10147-018-1306-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Docetaxel--administration & dosage<br/>Febrile Neutropenia--chemically induced<br/>Female<br/>Fluorouracil--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Incidence<br/>Japan--epidemiology<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Practice Guidelines as Topic--standards<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Young Adult